Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its latest quarterly report later this week. Market watchers are terzepetide USA supplier predicting strong growth driven by the continued success of Lilly's blockbuster treatments, particularly the diabetes franchise. However, there are also co